Evidence map›Paper›PMID 19427918›Full record

ArticleParasitology international2009

Enzymatic characterization of the Plasmodium vivax chitinase, a potential malaria transmission-blocking target.

Satoru Takeo, Daisuke Hisamori, Shusaku Matsuda, Joseph Vinetz, Jetsumon Sattabongkot, Takafumi Tsuboi

Abstract read
In one paragraph

Article in Parasitology international, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Plasmodium chitinases: revisiting a target of transmission-blockade against malaria.Protein science : a publication of the Protein Society · 2021
    Review
  4. A Hetero-Multimeric Chitinase-ContainingFrontiers in cellular and infection microbiology · 2020
    Article
  5. Article
  6. Novel biological activities of allosamidins.Molecules (Basel, Switzerland) · 2013
    Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Satoru TakeoCell-Free Science and Technology Research Center, Ehime University, 3 Bunkyo-cho, Matsuyama, Ehime 790-8577, Japan.
Daisuke Hisamori
Shusaku Matsuda
Joseph Vinetz
Jetsumon Sattabongkot
Takafumi Tsuboi
Ehime University · JPArmed Forces Research Institute of Medical Science · THUniversity of California, San Diego · US

Funding

MOLECULAR TARGETS OF BLOCKING MALARIA TRANSMISSIONR01AI045999 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI VINETZ, JOSEPH M. · 2000 to 2010
$3.2M
Patient-Oriented Research in Tropical Infectious DiseasesK24AI068903 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VINETZ, JOSEPH M. · 2006 to 2015
$1.5M
NIAID NIH HHS K24 AI068903NIAID NIH HHS R01 AI045999
6 · The paper itself

Abstract

The chitinase (EC 3.2.1.14) of the human malaria parasite Plasmodium falciparum, PfCHT1, has been validated as a malaria transmission-blocking vaccine (TBV). The present study aimed to delineate functional characteristics of the P. vivax chitinase PvCHT1, whose primary structure differs from that of PfCHT1 by having proenzyme and chitin-binding domains. The recombinant protein rPvCHT1 expressed with a wheat germ cell-free system hydrolyzed 4-methylumbelliferone (4MU) derivatives of chitin oligosaccharides (beta-1,4-poly-N-acetyl glucosamine (GlcNAc)). An anti-rPvCHT1 polyclonal antiserum reacted with in vitro-obtained P. vivax ookinetes in anterior cytoplasm, showing uneven patchy distribution. Enzymatic activity of rPvCHT1 shared the exclusive endochitinase property with parallelly expressed rPfCHT1 as demonstrated by a marked substrate preference for 4MU-GlcNAc(3) compared to shorter GlcNAc substrates. While rPvCHT1 was found to be sensitive to the general family-18 chitinase inhibitor, allosamidin, its pH (maximal in neutral environment) and temperature (max. at approximately 25 degrees C) activity profiles and sensitivity to allosamidin (IC50=6 microM) were different from rPfCHT1. The results in this first report of functional rPvCHT1 synthesis indicate that the P. vivax chitinase is enzymatically close to long form Plasmodium chitinases represented by P. gallinaceum PgCHT1.

Indexed as

ChitinasesAcetylglucosamineAnimalsChitinEnzyme InhibitorsEnzyme PrecursorsHumansHydrogen-Ion ConcentrationHymecromoneMalariaPlasmodium vivaxProtozoan ProteinsRecombinant ProteinsTemperatureTrisaccharidesAcetylglucosamineallosamidinChitinChitinasesEnzyme InhibitorsEnzyme PrecursorsHymecromonepfCHT1, chitinaseProtozoan ProteinsRecombinant ProteinsTrisaccharides

Identifiers

PMID19427918
PMCPMC2763513
OpenAlexW2029623603

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.